Ascenta Therapeutics
About:
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Website: http://www.ascenta.com
Top Investors: Sofinnova Investments, U.S. Venture Partners, Scale Venture Partners, Domain Associates, Enterprise Partners
Description:
Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis).
$87.8M
$10M to $50M
Malvern, Pennsylvania, United States
2003-01-01
info(AT)ascenta.com
Dajun Yang, Marc Lippman, Shaomeng Wang
51-100
2010-02-06
Private
© 2025 bioDAO.ai